Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
6.86 USD | -1.72% | +1.93% | -8.87% |
25/06 | Oppenheimer Initiates Coverage on Adverum Biotechnologies With Outperform Rating, $25 Price Target | MT |
11/06 | Adverum Biotechnologies, Inc. Announces Executive Changes | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-8.87% | 14Cr | |
+15.20% | 12TCr | |
+19.67% | 11TCr | |
+18.95% | 2.65TCr | |
-23.86% | 1.94TCr | |
-19.03% | 1.62TCr | |
-20.90% | 1.54TCr | |
-46.14% | 1.52TCr | |
+63.85% | 1.49TCr | |
+4.49% | 1.35TCr |
- Stock Market
- Equities
- ADVM Stock
- News Adverum Biotechnologies, Inc.
- Oppenheimer Initiates Coverage on Adverum Biotechnologies With Outperform Rating, $25 Price Target